
doi: 10.1038/218977a0
pmid: 5681248
THE range of chemical agents which can produce sterility in experimental male rodents is gradually increasing. (For recent surveys, see Jackson1,2.) The list includes nitroaromatic compounds, for example, nitrofuranes, nitrothiazoles and nitropyrroles, besides a variety of compounds of the alkylating category. Recently, a nitrothiazole derivative, niridazole (‘Ambilhar’), has been introduced for the treatment of schistosomiasis3,4 and part of its effective toxic action involves damage to the gonads of the male and female parasite. Reversible inhibition of spermatogenesis in mice by this compound has been described5. Here we wish briefly to record the ability of two simple unrelated substances, ethylenedimethanesulphonate (EDS) and hexamethylphosphoramide (HMPA) effectively to inhibit the reproductive capacity of Schistosoma mansoni within the mouse.
Male, Chemosterilants, Phosphates, Mice, Fertility, Infertility, Animals, Schistosoma, Schistosomiasis, Female, Sulfonic Acids, Gonads, Infertility, Female, Infertility, Male
Male, Chemosterilants, Phosphates, Mice, Fertility, Infertility, Animals, Schistosoma, Schistosomiasis, Female, Sulfonic Acids, Gonads, Infertility, Female, Infertility, Male
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 12 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
